Analytical Data
-
基因名
ACRBP
- Application
-
别名
ACRBP; ACRBP_HUMAN; acrosin binding Protein; Acrosin binding Protein precursor
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8NEB7
-
表达区间
26-543aa
-
氨基酸序列
QDSTQ ASTPGSPLSP TEYERFFALL TPTWKAETTC RLRATHGCRN PTLVQLDQYE NHGLVPDGAV CSNLPYASWF ESFCQFTHYR CSNHVYYAKR VLCSQPVSIL SPNTLKEIEA SAEVSPTTMT SPISPHFTVT ERQTFQPWPE RLSNNVEELL QSSLSLGGQE QAPEHKQEQG VEHRQEPTQE HKQEEGQKQE EQEEEQEEEG KQEEGQGTKE GREAVSQLQT DSEPKFHSES LSSNPSSFAP RVREVESTPM IMENIQELIR SAQEIDEMNE IYDENSYWRN QNPGSLLQLP HTEALLVLCY SIVENTCIIT PTAKAWKYME EEILGFGKSV CDSLGRRHMS TCALCDFCSL KLEQCHSEAS LQRQQCDTSH KTPFVSPLLA SQSLSIGNQV GSPESGRFYG LDLYGGLHMD FWCARLATKG CEDVRVSGWL QTEFLSFQDG DFPTKICDTD YIQYPNYCSF KSQQCLMRNR NRKVSRMRCL QNETYSALSP GKSEDVVLRW SQEFSTLTLG QFG
-
分子量
61.3 KDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ACRBP (Ankyrin-Repeat Containing Protein), a member of the ankyrin-repeat family, has garnered significant interest in recent years due to its potential roles in various biological processes and diseases. Initially identified as a protein involved in intracellular signaling pathways and protein-protein interactions, ACRBP has been implicated in regulating cell cycle progression, apoptosis, and stress responses. Its expression levels have been associated with several cancers, suggesting that ACRBP could serve as a biomarker for tumor progression and a potential therapeutic target. Researchers have sought to understand the structural and functional dynamics of ACRBP through recombinant protein studies, allowing them to elucidate its mechanisms of action and interactions with other cellular components. The use of recombinant DNA technology has enabled the production of ACRBP in various expression systems, facilitating studies on its biochemical properties, interaction networks, and effects on cellular functions. This research is crucial for uncovering the role of ACRBP in health and disease, paving the way for novel approaches in cancer therapy and other related fields. As such, ACRBP represents a promising focus of study within molecular biology and biomedical research, helping to bridge the gap between fundamental biology and potential clinical applications.
